SGLT2 Adjunct in T1D

NCT07591077 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Nephropathy, Diabetic

Interventions

DRUG: Empagliflozin (EMPA)
OTHER: Placebo

Sponsor

Ain Shams University